Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors
  • Library

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, China
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Our sub-categories
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2025
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Galderma Insights
    • Podcasts
  • Innovation
    • Bringing innovation to life
    • Partnerships
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Investors
You searched for: «【✈️ Telegram ID: KPU77】 대성피 성인 피시방 안전 보장 100% 알거래 중개소 리스트 - 용인»
Results 81 - 85 of 155
Page 17 of 31
  1. Media
  2. Newsroom

AstraZeneca and Galderma enter into R&D collaboration to develop new treatments for dermatological diseases

March 7, 2011- AstraZeneca and Galderma Pharma S.A.

  1. Media
  2. Newsroom

Galderma receives U.S. FDA approval for Restylane® Contour™ for the correction of temple hollowing

 

  1. Media
  2. Newsroom

Galderma launches a virtual experience this Rosacea Awareness Month showcasing how the condition goes beyond the visible with Rosacea Space

  • Galderma is calling on the rosacea community and their friends and family to submit artistic creations to Rosacea Space this Rosacea Awareness Month, illustrating what rosacea means to them
  • Content from prominent artists and influencers will feature on the dedicated site www.rosaceaspace.com, connecting those impacted by rosacea worldwi
  1. Media
  2. Newsroom

Galderma Announces New England Journal of Medicine Publication from Phase 2 Study of Investigational Therapy Nemolizumab in Patients with Moderate to Severe Prurigo Nodularis

  • Results from Phase 2 study published in the New England Journal of Medicine.
  • Nemolizumab met the primary endpoint of a greater improvement in Peak Pruritus Numerical rating scale (PP-NRS) from baseline to Week 4 compared to placebo.
  • Nemolizumab was recently granted FDA Breakthrough Therapy Designation for the treatment of patients suffering fro
  1. Media
  2. Newsroom

Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula

First and Only Hyaluronic Acid Dermal Filler for Cheeks with Cannula1 Now Offers Aesthetic Professionals New Delivery Method of Injectable Treatment 

 

Results 81 - 85 of 155
Page 17 of 31

Pagination

  • Previous page Previous Page
  • Next page Next Page
  1. Home
  2. Search results

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2026

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back